Abel Hall »

Ovid Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-12-31 $51k 31k 1.63
2025-09-30 $42k 32k 1.30
2025-06-30 $11k 32k 0.33
2025-03-31 $3.2k 10k 0.31

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Affinity Asset Advisors
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Point72 Asset Management
Vanguard Group
Saturn V Capital Management
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management

View all funds holding Ovid Therapeutics